SNSE
Price
$0.45
Change
+$0.02 (+4.65%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
VSTM
Price
$4.19
Change
-$0.25 (-5.63%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

SNSE vs VSTM

Header iconSNSE vs VSTM Comparison
Open Charts SNSE vs VSTMBanner chart's image
Sensei Biotherapeutics
Price$0.45
Change+$0.02 (+4.65%)
Volume$5.1K
CapitalizationN/A
Verastem
Price$4.19
Change-$0.25 (-5.63%)
Volume$17.02K
CapitalizationN/A
SNSE vs VSTM Comparison Chart
Loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNSE vs. VSTM commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNSE is a Hold and VSTM is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (SNSE: $0.45 vs. VSTM: $4.19)
Brand notoriety: SNSE and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNSE: 46% vs. VSTM: 158%
Market capitalization -- SNSE: $11.32M vs. VSTM: $186.7M
SNSE [@Biotechnology] is valued at $11.32M. VSTM’s [@Biotechnology] market capitalization is $186.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNSE’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • SNSE’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both SNSE and VSTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNSE’s TA Score shows that 2 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • SNSE’s TA Score: 2 bullish, 6 bearish.
  • VSTM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than SNSE.

Price Growth

SNSE (@Biotechnology) experienced а +2.25% price change this week, while VSTM (@Biotechnology) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

SNSE is expected to report earnings on Mar 06, 2025.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($187M) has a higher market cap than SNSE($11.3M). SNSE YTD gains are higher at: -34.986 vs. VSTM (-48.526). SNSE has higher annual earnings (EBITDA): -28.38M vs. VSTM (-88.92M). VSTM has more cash in the bank: 113M vs. SNSE (47M). SNSE has less debt than VSTM: SNSE (4.47M) vs VSTM (41.4M). VSTM has higher revenues than SNSE: VSTM (10M) vs SNSE (0).
SNSEVSTMSNSE / VSTM
Capitalization11.3M187M6%
EBITDA-28.38M-88.92M32%
Gain YTD-34.986-48.52672%
P/E RatioN/AN/A-
Revenue010M-
Total Cash47M113M42%
Total Debt4.47M41.4M11%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNSEVSTM
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 28 days ago
73%
Bullish Trend 21 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEFYX17.980.22
+1.24%
MassMutual Mid Cap Growth Svc
FGITX43.340.50
+1.17%
Fidelity Advisor Growth & Income M
FSCAX31.890.27
+0.85%
Nuveen Small Cap Value A
RYSGX51.550.20
+0.39%
Rydex S&P SmallCap 600 Pure Growth A
EKGYX39.210.13
+0.33%
Allspring Special Global Small Cap Admin

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+4.63%
VSTM - SNSE
49%
Loosely correlated
-5.63%
ALZN - SNSE
40%
Loosely correlated
-11.20%
FATE - SNSE
36%
Loosely correlated
+1.20%
GRI - SNSE
34%
Loosely correlated
-3.90%
GOSS - SNSE
34%
Loosely correlated
-0.11%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with SNSE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-5.63%
SNSE - VSTM
49%
Loosely correlated
+4.63%
GNLX - VSTM
48%
Loosely correlated
+3.65%
ZLDAF - VSTM
47%
Loosely correlated
N/A
TGTX - VSTM
38%
Loosely correlated
+4.04%
MDGL - VSTM
37%
Loosely correlated
+5.12%
More